4
Changes in Ownership
Humacyte, Inc. Filed Acc 0001628280-25-052715
Options or other derivatives
- President, CEO and Director acquired 311,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Niklason Laura E · President, CEO and Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-16 | Grant or award : show line 1 in the form Stock Options (right to buy) | +311,100 | 311,100 | D |
Loading xslF345X05/wk-form4_1763419703.xml…